Literature DB >> 4722915

BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.

J Gutterman, G Mavligit, C McBride, E Frei, E M Hersh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4722915     DOI: 10.1002/1097-0142(197308)32:2<321::aid-cncr2820320207>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

5.  Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer.

Authors:  H D Adolphs; J Thiele; H Kiel
Journal:  Urol Res       Date:  1979-06-22

6.  Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin.

Authors:  M Sakita; A Takenaka; T Yamane; M Kasuga; Y Fujita; S Majima
Journal:  Jpn J Surg       Date:  1984-09

7.  Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.

Authors:  H Biran; J L Moake; R C Reed; J U Gutterman; E M Hersh; E J Freireich; G M Mavligit
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

8.  Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.

Authors:  V K Lui; J Karpuchas; P B Dent; P B McCulloch; M A Blajchman
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.